Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study

To examine changes in performance and outcomes of pelvic exenteration for gynecologic malignancies. This is a population-based retrospective study examining the Nationwide Inpatient Sample between 2001 and 2015. Women with cervical, uterine, vaginal, and vulvar malignancies who underwent pelvic exenteration were examined. Comorbidity, perioperative complications, total charges, length of stay, and mortality were assessed. There were 2647 cases included. Cervical cancer was the most common malignancy (45.1%), followed by vaginal cancer (27.6%). 26.9% of women had a Charlson Comorbidity Index ≥3, which significantly increased from 23.3% in 2001–2005 to 33.3% in 2011–2015 (42.9% relative increase, P